Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future

Author(s):  Rabi Joseph

Issue:  Mar/Apr 2016 - Volume 20, Number 2
View All Articles in Issue

Page(s):  107-113

Note:  Electronic version includes supplemental material.

Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Page 1
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Page 2
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Page 3
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Page 4
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Page 5
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Page 6
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Page 7

Download in electronic PDF format for $75

Abstract:  Ketamine, an N-methyl-D-aspartate antagonist, is an anesthetic used for general anesthesia. In the past 20 years, ketamine has been successfully formulated topically and has been used for analgesia. Topical analgesics are popular among physicians due to their efficacy and limited systemic effects. With the rise in compounding pharmacies in the U.S., the use of topical ketamine compounded with various bases and other analgesics has been increasing. There are numerous small studies examining the efficacy and safety of topical ketamine mainly on neuropathic pain. In this article, a narrative review examining topical ketamine‚Äôs mechanism, pharmacology, use, safety, and future will be analyzed.

Related Keywords: Joseph Rabi, MD, ketamine, topical preparations, N-methyl-D-aspartate, glutamate NMDA antagonist, anesthesia, anesthetic, analgesic, pain relief, analgesia, pain control, neuropathic pain, adverse effects, patient adherence, postherpetic neuralgia, shingles, herpes zoster, literature review, complex regional pain syndrome, diabetic neuropathy, chemotherapy-induced peripheral neuropathy, mechanisms of action, anti-inflammatory agent, pelvic pain, radiculopathy, laminectomy, failed back syndrome, compression neuropathy, erythromelalgia, pruritus, itching, radiation dermatitis, orofacial pain, drug safety, inflammation, inflammatory pain, nociceptive pain, nociception, drug vehicle

Related Categories: PAIN MANAGEMENT, PATIENT COMPLIANCE, DOSAGE FORMS/DRUG CARRIERS, LITERATURE REVIEW, NEUROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
Mar/Apr 2016
Pg. 107-113

Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Rabi Joseph
, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
Nov/Dec 2016
Pg. 517-520

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015
Pg. 295-300

Topical Ketamine in the Treatment of Complex Regional Pain Syndrome
Durham Melissa J
, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
Mar/Apr 2018
Pg. 172-175

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott
, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 182-192

Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
May/Jun 2010
Pg. 200-203

Ketamine for Pain in Hospice Patients
Wood Robert M
Jul/Aug 2000
Pg. 253-254

Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Zur Eyal
Jan/Feb 2014
Pg. 14-19

A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications
Warner Meredith
, Tuder Dmitry
May/Jun 2014
Pg. 182-188

Update on Managing Neuropathic Pain
McNulty Jack P
, Muller George
May/Jun 2009
Pg. 182-190

Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G
, Pepin Steven M
May/Jun 2009
Pg. 218-219

Levorphanol for the Treatment of Severe Chronic Pain
McNulty Jack P
May/Jun 2007
Pg. 202-211

PostScription: Treatment of Chronic Pain with Methadone or Levorphanol
McNulty Jack P
Mar/Apr 2006
Pg. 159-160

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Topical Treatment of Neuropathic Pain
Vadaurri Vince
May/Jun 2008
Pg. 182-190

Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen
Zugerman Jessie Jean M
, Reed Thomas C
Nov/Dec 2007
Pg. 514-519

Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Shakshuki Ayah
, Agu Remigius U
Nov/Dec 2019
Pg. 496-503

Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report
McNulty Jack P
, Hahn Kristian
Sep/Oct 2012
Pg. 364-368

Pain: Systematic Review of Pharmacy Compounding of Pain Medication
Shawaqfeh Mohammad S
, Harrington Catherine
Jan/Feb 2018
Pg. 19-24

Return to Top